홈 › 다발성 골수종 › 노스캐롤라이나 › Durham
NC Durham의 다발성 골수종 임상 시험
다발성 골수종 관련 연구 37개가 Durham 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중3상
- Durham VAMC, Durham
- University of North Carolina, Chapel Hill · 10마일 거리
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중3상
- Duke University Medical Center, Durham
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
피험자 모집 중2상
- Duke University Medical Center, Durham
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
피험자 모집 중3상
- Durham VAMC, Durham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
피험자 모집 중2상
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
피험자 모집 중2/3상
- University of North Carolina at Chapel Hill /ID# 277708, Chapel Hill · 10마일 거리
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
피험자 모집 중3상
- Duke University, Durham
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
피험자 모집 중1/2상
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10마일 거리
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중2상
- University of North Carolina Medical Center, Chapel Hill · 10마일 거리
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
피험자 모집 중2상
- Duke University Health System, Durham
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
피험자 모집 중3상
- Research Site, Chapel Hill · 10마일 거리
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1상
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13마일 거리
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
피험자 모집 중1/2상
- GSK Investigational Site, Chapel Hill · 10마일 거리
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
피험자 모집 중1상
- Duke University Hospital, Durham
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
피험자 모집 중1/2상
- Research Site, Durham
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
피험자 모집 중3상
- Research Site, Durham
- Research Site, Chapel Hill · 10마일 거리
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
피험자 모집 중
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10마일 거리
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
피험자 모집 중1상
- Duke Cancer Center, Durham
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
피험자 모집 중2상
- UNC Hospitals Adult Oncology Clinics, Chapel Hill · 10마일 거리
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
피험자 모집 중1/2상
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10마일 거리
Selinexor and Backbone Treatments of Multiple Myeloma Patients
피험자 모집 중1/2상
- Duke Institute of Cancer/ Duke University, Durham
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1상
- University of North Carolina /ID# 251203, Chapel Hill · 10마일 거리
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
피험자 모집 중1상
- University of North Carolina at Chapel Hill, Chapel Hill · 10마일 거리
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
피험자 모집 중2상
- University of North Carolina (Data Collection Only), Chapel Hill · 10마일 거리
Registry of Older Patients With Cancer
피험자 모집 중관찰 연구
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10마일 거리
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
피험자 모집 중2상
- University of North Carolina, Chapel Hill · 10마일 거리
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
피험자 모집 중3상
- Duke University, Durham
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
피험자 모집 중2상
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
피험자 모집 중1상
- University of North Carolina Hospitals at Hillsborough, Chapel Hill · 10마일 거리
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
피험자 모집 중1/2상
- Duke University Health System (DUHS), Durham
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1상
- University Of North Carolina Health Care - Hillsborough Campus /ID# 278230, Hillsborough · 13마일 거리
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
피험자 모집 중1상
- University of North Carolina, Chapel Hill · 10마일 거리
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
피험자 모집 중1상
- University of North Carolina, Chapel Hill · 10마일 거리
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
피험자 모집 중1/2상
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10마일 거리
Registry for Adults With Plasma Cell Disorders (PCD's)
피험자 모집 중관찰 연구
- North Carolina Cancer Hospital, Chapel Hill · 10마일 거리
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
피험자 모집 중관찰 연구
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10마일 거리
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
피험자 모집 중1상
- Duke University Health System (DUHS), Durham
다른 도시의 다발성 골수종 시험
- New York City, NY연구 60개
- Boston, MA연구 42개
- Atlanta, GA연구 41개
- Houston, TX연구 38개
- Nashville, TN연구 32개
- Denver, CO연구 26개
- Columbus, OH연구 24개
- St. Louis, MO연구 23개
- Baldwin Park, CA연구 23개
- Rochester, MN연구 23개
- Washington, DC연구 22개
- Seattle, WA연구 22개
Durham의 다른 연구
- 유방암연구 63개
- 암 (전체)연구 59개
- 비소세포폐암연구 39개
- 급성 골수성 백혈병연구 33개
- 전이성 암연구 33개
- 폐암연구 32개
- 전립선암연구 32개
- 대장직장암연구 28개
- 만성 림프구성 백혈병연구 27개
- 난소암연구 27개
- 심부전연구 26개
- 췌장암연구 25개
ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.